The Ethical Case for Decentralized Clinical Trials
Ethics & Human Research · 2024
DOI: 10.1002/eahr.500229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ethics & Human Research, 2024. Verfasst von Kathryn Muyskens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research fellow at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Singapore Ministry of Health's National Medical Research Council under its Science, Health, and Policy Relevant Ethics, Singapore (SHAPES) program.
Abstract (Originalsprache)
The recent pandemic spurred interest in innovative design for clinical trials. In particular, constraints on the public's ability to gather led to an increase in remote or decentralized clinical trials (DCTs). DCTs present an opportunity to extend the benefits of research to underserved populations, decrease burdens, increase access to trials, and fill knowledge gaps surrounding rare conditions, though they are not without their own unique challenges and risks. These risks are far from irremediable, and the advantages are significant enough to merit attention. There is a scientific and moral case to increase the use of DCTs beyond the context of public health emergencies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Research fellow at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore.
- Research assistant at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore.
- Professor of bioethics at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore and a Senior Fellow in the Faculty of Law at the National University of Singapore.
- Assistant professor of ethics at the Centre for Biomedical Ethics in the Yong Loo Lin School of Medicine at the National University of Singapore.
Förderung
- Singapore Ministry of Health's National Medical Research Council under its Science, Health, and Policy Relevant Ethics, Singapore (SHAPES) program
Zitieren
APA
Muyskens, K., Teo, I. Z. Y., Menikoff, J., & Schaefer, G. O. (2024). The Ethical Case for Decentralized Clinical Trials. Ethics & Human Research. https://doi.org/10.1002/eahr.500229
Vancouver
Muyskens K, Teo IZY, Menikoff J, Schaefer GO. The Ethical Case for Decentralized Clinical Trials. Ethics & Human Research. 2024. doi:10.1002/eahr.500229
BibTeX
@article{Muyskens2024,
author = {Muyskens, Kathryn and Teo, Ivan Z Y and Menikoff, Jerry and Schaefer, G Owen},
title = {The Ethical Case for Decentralized Clinical Trials},
journal = {Ethics & Human Research},
year = {2024},
doi = {10.1002/eahr.500229}
}
EUVIMED